These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Hydroxychloroquine in patients with inflammatory and erosive osteoarthritis of the hands (OA TREAT): study protocol for a randomized controlled trial. Detert J; Klaus P; Listing J; Höhne-Zimmer V; Braun T; Wassenberg S; Rau R; Buttgereit F; Burmester GR Trials; 2014 Oct; 15():412. PubMed ID: 25348033 [TBL] [Abstract][Full Text] [Related]
4. Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug use. Proudman SM; Keen HI; Stamp LK; Lee AT; Goldblatt F; Ayres OC; Rischmueller M; James MJ; Hill CL; Caughey GE; Cleland LG Semin Arthritis Rheum; 2007 Oct; 37(2):99-111. PubMed ID: 17391739 [TBL] [Abstract][Full Text] [Related]
5. Current concepts regarding pharmacologic treatment of rheumatoid and osteoarthritis. Wildy KS; Wasko MC Hand Clin; 2001 May; 17(2):321-38, xi. PubMed ID: 11478054 [TBL] [Abstract][Full Text] [Related]
6. Soluble interleukin 2 receptors and treatment with hydroxychloroquine in erosive osteoarthritis. Punzi L; Bertazzolo N; Pianon M; Michelotto M; Todesco S J Rheumatol; 1996 Aug; 23(8):1477-8. PubMed ID: 8856633 [No Abstract] [Full Text] [Related]
7. The role of anti-malarials in rheumatoid arthritis--the American experience. Khraishi MM; Singh G Lupus; 1996 Jun; 5 Suppl 1():S41-4. PubMed ID: 8803910 [TBL] [Abstract][Full Text] [Related]
8. How aggressive should initial therapy for rheumatoid arthritis be? Factors associated with response to 'non-aggressive' DMARD treatment and perspective from a 2-yr open label trial. Matteson EL; Weyand CM; Fulbright JW; Christianson TJ; McClelland RL; Goronzy JJ Rheumatology (Oxford); 2004 May; 43(5):619-25. PubMed ID: 14983105 [TBL] [Abstract][Full Text] [Related]
9. [Pharmacotherapy of patients with (early) rheumatoid arthritis]. Jacobs JW; Blaauw AA; Dijkmans BA; van Riel PL; Bijlsma JW Ned Tijdschr Geneeskd; 2000 Jan; 144(5):211-6. PubMed ID: 10682647 [TBL] [Abstract][Full Text] [Related]
10. Prognostic factors in a large cohort of patients with early undifferentiated inflammatory arthritis after application of a structured management protocol. Quinn MA; Green MJ; Marzo-Ortega H; Proudman S; Karim Z; Wakefield RJ; Conaghan PG; Emery P Arthritis Rheum; 2003 Nov; 48(11):3039-45. PubMed ID: 14613264 [TBL] [Abstract][Full Text] [Related]
11. Advances in the management of osteoarthritis and rheumatoid arthritis. Ollivier JE JAAPA; 2001 Oct; 14(10):22-5, 29-30, 36-8. PubMed ID: 11715673 [No Abstract] [Full Text] [Related]
12. [Medication a complement to other forms of pain management in osteoarthritis]. Petersson I Lakartidningen; 2002 Nov; 99(46):4647-50. PubMed ID: 12486970 [TBL] [Abstract][Full Text] [Related]
13. Treatment options for osteoarthritis: considerations for older adults. Seed SM; Dunican KC; Lynch AM Hosp Pract (1995); 2011 Feb; 39(1):62-73. PubMed ID: 21441760 [TBL] [Abstract][Full Text] [Related]
14. Hydroxychloroquine in the treatment of erosive osteoarthritis. Bryant LR; des Rosier KF; Carpenter MT J Rheumatol; 1995 Aug; 22(8):1527-31. PubMed ID: 7473478 [TBL] [Abstract][Full Text] [Related]
15. [The role of the conventional drugs in the treatment of rheumatoid arthritis]. Fantini F Recenti Prog Med; 2003; 94(7-8):330-8. PubMed ID: 12868241 [TBL] [Abstract][Full Text] [Related]
17. Medical treatment of adolescents with rheumatic disease. Hollister JR Adolesc Med; 1998 Feb; 9(1):163-70, vii. PubMed ID: 10961259 [TBL] [Abstract][Full Text] [Related]